Showing results (341-350 of 435) with videos related to
Sort By:
Pageof 44
Frontiers in Genetics|April 11, 2022
TP53 /KRAS Co-Mutations Create Divergent Prognosis Signatures in Intrahepatic CholangiocarcinomaChunguang Guo, Zaoqu Liu, Yin Yu, et al.Frontiers in Oncology|November 15, 2021
Derivation and Clinical Validation of a Redox-Driven Prognostic Signature for Colorectal CancerQin Dang, Zaoqu Liu, Shengyun Hu, et al.Frontiers in Immunology|August 16, 2021
Clinical Significance and Inflammatory Landscape of aNovel Recurrence-Associated Immune Signature in Stage II/III Colorectal CancerZaoqu Liu, Taoyuan Lu, Jing Li, et al.Cancer Biology & Therapy|February 8, 2023
The impact of drug-eluting bead (vs. conventional) transarterial chemoembolization on hepatic fibrosis in treating intermediate or advanced hepatocellular carcinomaHao Li, Chao Liang, Donglin Kuang, et al.International Journal of Biological Sciences|October 20, 2022
Engineering neoantigen vaccines to improve cancer personalized immunotherapyZaoqu Liu, Jinxiang Lv, Qin Dang, et al.International Immunopharmacology|September 13, 2024
Proteogenomics offers a novel avenue in neoantigen identification for cancer immunotherapyYuqing Ren, Yi Yue, Xinyang Li, et al.Cellular Signalling|November 10, 2023
MPDZ is associated with immune infiltration and regulates migration and invasion by switching YAP1 phosphorylation in colorectal cancerZhuang Chen, Yuhao Ba, Nannan Zhao, et al.Virology|April 29, 2017
Discovery and mechanism of action of Novel Baicalein modified derivatives as potent antihepatitis agentJi Ma, Tengfei Li, Xinwei Han, et al.Journal of Immunology Research|August 24, 2021
Screening Prognosis-Related lncRNAs Based on WGCNA to Establish a New Risk Score for Predicting Prognosis in Patients with Hepatocellular CarcinomaXueliang Zhou, Mengmeng Dou, Zaoqu Liu, et al.Frontiers in Bioscience (Landmark Edition)|December 29, 2015
Role of microRNAs in metastasis of non-small cell lung cancerShengLei Li, Ming Gao, ZongMing Li, et al.Pageof 44